Jane Chin, Ph.D.

Pharma Patient Connection: Insight is the Missing Link to Authenticity

This is based on a presentation I gave to DTC Perspectives’ Marketing to the Digital Consumer conference, October 12-13, 2011 in Fairfield New Jersey. Authenticity in Pharma-Patient Connection

Read the full article →

Can pharma really afford to “be more human”?

The recent hullabaloo with some pharma companies pulling out of Facebook got me thinking about whether it is even probable for pharma companies to come across as “more human” and therefore viewed as willing to connect with consumers/patients beyond the PR and marketing scripts. For example, can pharma companies — whether on Twitter or Facebook [...]

Read the full article →

Pharma Companies that Can’t Handle Comments Should Get Off Facebook, Good Riddance!

Jonathan at Dose of Digital talks about pharma’s fear of Facebook pages centering around 2 issues that pharma thinks require 24/7 monitoring: Adverse Events and negative publicity. I hear the same excuse on why pharma companies are so scared to look at patient comments on blogs: adverse events. I’m sorry, but adverse events are happening [...]

Read the full article →

Entrepreneurs? Please — Disrupt Healthcare!

I was inspired to write this post to answer a question on Quora: “Can a consumer internet entrepreneur cross over into the healthcare space with limited domain expertise?” Absolutely. But you will need – A compelling motive. I know of a CEO who was trained as a lawyer. Her child had a rare disease and [...]

Read the full article →

Stop Pretending You Don’t Know, Pharma Companies!

I remembered years ago I was speaking to a Forest employee who told me how proud she was to be working at Forest because of how ethical the company and the CEO was. That same employee was critical of me for talking to the WSJ about some of the less ethical practices that pharma companies [...]

Read the full article →

← Previous Entries